Newbridge Financial Services Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.38K | Hold |
1,260
| – | – | ﹤0.01% | 984 |
|
|
2025
Q1 | $6.67K | Sell |
1,260
-1,200
| -49% | -$6.35K | ﹤0.01% | 751 |
|
|
2024
Q4 | $16.6K | Hold |
2,460
| – | – | ﹤0.01% | 644 |
|
|
2024
Q3 | $16.2K | Buy |
2,460
+120
| +5% | +$791 | 0.01% | 381 |
|
|
2024
Q2 | $17.6K | Hold |
2,340
| – | – | 0.01% | 600 |
|
|
2024
Q1 | $23.3K | Buy |
2,340
+2,140
| +1,070% | +$21.3K | 0.01% | 567 |
|
|
2023
Q4 | $1.97K | Sell |
200
-300
| -60% | -$2.96K | ﹤0.01% | 971 |
|
|
2023
Q3 | $3.83K | Buy |
+500
| New | +$3.83K | ﹤0.01% | 990 |
|